Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XM4G
|
|||
| Former ID |
DIB010823
|
|||
| Drug Name |
Bindarit
|
|||
| Synonyms |
Bindarit, Angelini Pharmaceuticals; CCL2 inhibitor (inflammatory disorders/kidney disease), Angelini Pharmaceuticals; MCP-1 inhibitor (inflammatory disorder/kidney disease), Angelini Pharmaceuticals
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Nephritis [ICD-11: GB40] | Phase 3 | [1] | |
| Company |
Angelini Pharmaceuticals SpA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H20N2O3
|
|||
| Canonical SMILES |
CC(C)(C(=O)O)OCC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3
|
|||
| InChI |
1S/C19H20N2O3/c1-19(2,18(22)23)24-13-16-15-10-6-7-11-17(15)21(20-16)12-14-8-4-3-5-9-14/h3-11H,12-13H2,1-2H3,(H,22,23)
|
|||
| InChIKey |
MTHORRSSURHQPZ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 130641-38-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bindarit: an anti-inflammatory small molecule that modulates the NF B pathway. Cell Cycle. 2012 Jan 1;11(1):159-69. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.